Opus Genetics, Inc. · NASDAQ:IRD

Opus Genetics, Inc. insider trades

Opus Genetics, Inc.'s insiders made 0 buys and 13 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Sep 30, 2026Foundation Fighting Blindness Retinal Degeneration FundSale556,000US$5Form 4
Sep 3, 2026Gagnon Robert E.Sale28,000US$5Form 4
Jul 23, 2026Yerxa Benjamin RSale7,429US$3Form 4
Jul 23, 2026Schachle Joseph KSale4,644US$3Form 4
Jul 23, 2026Magrath GeorgeSale9,475US$3Form 4
Jul 23, 2026Gagnon Robert E.Sale7,783US$3Form 4
May 18, 2026Foundation Fighting Blindness Retinal Degeneration FundSale1,700,000US$4Form 4
Apr 23, 2026Yerxa Benjamin RSale7,470US$5Form 4
Apr 23, 2026Schachle Joseph KSale4,697US$5Form 4
Apr 23, 2026Zaremba Rabourn AmySale1,641US$5Form 4

Opus Genetics, Inc. shareholders